EPISODE · Apr 4, 2020 · 13 MIN
Dupilumab for Severe Pediatric Atopic Dermatitis
from HCPLive Podcasts · host HCPLive.com
Amy S. Paller, MD, principal investigator of the phase 3 LIBERTY AD PEDS trial, discusses the add-on biologic's benefit for young patients and potential as a pediatrc allergic therapy.
NOW PLAYING
Dupilumab for Severe Pediatric Atopic Dermatitis
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m